Oruka Therapeutics, Inc.
ORKABiotechnology
$96.87+0.23%As of Oct 30vs prior close
- Market cap
- $6.4B
- From 52W high
- −14.33%
- EPS (YE23)
- -$0.37
- Revenue (YE23)
- $0
- Dividend yield
- –
Nomior Score
69
Steady ProfileSpeculativeTop 11% of the scored universe
Growth—
Quality57
Value63
Momentum96
Resilience44
Growth
$0revenue, YE23
YE15 $0YE23 $0
Connections
Who owns it
2funds, 1 tracked portfolio